X

Pharmaceutical

Pfizer Limited Q3FY23 Earnings Story

Pfizer Ltd is primarily involved in marketing, exporting, manufacturing, and trading of pharmaceutical products. It produces goods through its in-house…

Panacea Biotec Q3FY23; 26% Fall in Revenue

Panacea Biotec Limited’s revenue in Q3FY23 fell 26% to ₹ 11,520 lakhs. Consolidated Profit After Tax came at ₹ 1,937…

Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Transcript

Lupin Ltd (NSE:LUPIN) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vinita Gupta -- Chief Executive Officer Ramesh Swaminathan -- Executive Director,…

Lupin Limited Q3FY23; 47% Growth in Profits

Lupin Limited’s revenue in Q3FY23 rose 13% to ₹ 1,97,66,301 lakhs. Consolidated Profit After Tax came at ₹ 8,34,871 lakhs…

Sun Pharmaceutical Q3FY23; 3% Growth in Profits

Sun Pharmaceutical Industries Limited’s revenue in Q3FY23 rose 14% to ₹ 112,410 millions. Consolidated Profit After Tax came at ₹…

Aurobindo Pharma Q2FY23; 41% Fall in Profits

Aurobindo Pharma Ltd.‘s revenue in Q2FY23 fell 3% to ₹ 5,739 crores. Consolidated Profit came at ₹ 409 crores showcasing…

Divi’s Laboratories Q2FY23; 19% Fall in Profits

Divi's Laboratories Ltd.'s revenues in Q2FY23 fell 7% to ₹ 1,855 crores. Consolidated Profit came at ₹ 494 crores showcasing…

Torrent Pharmaceuticals Limited Q2FY23; Profits down by 1%

Torrent Pharmaceuticals Ltd.‘s Revenues for Q2 FY23 has increased by 7% YoY to ₹ 2,291 crores. Net Profit fell by…

Apollo Hospitals Enterprise Limited Q1FY23; 35% fall in Profits

Revenue for Q1 FY23 has increased by 1% YoY to ₹ 37,956 millions. Profits have fallen by 35% YoY to…

Aurobindo Pharma Limited Q1FY23; 32% fall in Profits

Revenue for Q1 FY23 has increased by 9% YoY to ₹ 6,235.9 crores. Profits have fallen by 32% YoY to…

Zydus Lifesciences Ltd Q1FY23; Profit suffer with rise in expenses

Revenue for Q1 FY23 has increased by 1.8% YoY to ₹40,727 millions. Profits decreased by 12% YoY to ₹5,183 millions…

Piramal Enterprises Limited Q1FY23; 8% fall in Profits

Revenue for Q1 FY23 has increased by 22% YoY to ₹ 3,548 crores. Profits have fallen by 8% YoY to…

Dr Reddy’s Laboratories Ltd. Q1FY23; 6% growth in Revenue

Revenue for Q1 FY23 has increased by 6% YoY to ₹ 52,154 millions. Profits have grown by 108% YoY to…